Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,330
-10 (-0.07%)
Last updated: Apr 17, 2025

Daewon Pharmaceutical Market Cap

Daewon Pharmaceutical has a market cap or net worth of 286.57 billion as of April 17, 2025. Its market cap has decreased by -11.17% in one year.

Market Cap
286.57B
Enterprise Value
436.99B
Revenue
598.16B
Ranking
n/a
PE Ratio
18.97
Stock Price
13,330.00

Market Cap Chart

Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 286.57B, an increase of 1,486.75%. That is a compound annual growth rate of 12.13%.

History

DateMarket Cap% Change
Apr 18, 2025286.57B-6.18%
Dec 30, 2024305.43B-7.98%
Dec 28, 2023331.93B-15.58%
Dec 29, 2022393.20B14.64%
Dec 30, 2021343.00B-9.91%
Dec 30, 2020380.71B13.65%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 74.66T
Celltrion 33.89T
ALTEOGEN 20.94T
Yuhan 8,633.29B
SK Biopharmaceuticals 8,207.23B
HLB Co., Ltd. 7,214.15B
Peptron 4,195.85B
LigaChem Biosciences 3,958.37B
Market Cap Rankings